Centiva Capital, LP Amicus Therapeutics, Inc. Transaction History

Centiva Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $140,278 - $177,705	-14,285 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $124,850 - $169,134	14,285 New	14,285 $137,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $251,067 - $463,924	-18,639 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $204,860 - $252,539	-15,893 Reduced 46.02%	18,639 $263,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $305,953 - $541,807	34,532 New	34,532 $521,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $109,514 - $184,340	-16,518 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $41,065 - $59,017	5,490 Added 49.78%	16,518 $161,000
Q3 2019 Nov 13, 2019	SELL	$8.02 - $13.25 $312 - $516	-39 Reduced 0.35%	11,028 $88,000
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $121,294 - $159,364	11,067 New	11,067 $138,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.